Rising stress levels are contributing to an increase in stress-induced bruxism, which can lead to significant dental damage if not detected and treated early. A 2021 survey by the American Dental ...
The product, aimed at controlling surgical bleeding, is already available for ... focusing on innovative healthcare solutions. The company operates the world's largest network of plasma donation ...
Grifols (GRFS) announced that its plasma-protein based fibrin sealant, FS, for controlling surgical bleeding has received approval from the United States Food and Drug Administration, FDA ...
Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasis Grifols surgical bleeding management ...
The FS solution is now available in 18 countries. In early 2023, Grifols announced that it had met all primary and secondary endpoints of its phase 3b study evaluating the administration of ...
The product, aimed at controlling surgical bleeding, is already available for children and adolescents in Europe ... Grifols, headquartered in Barcelona, continues to expand its portfolio, focusing on ...
Dr. Uwe Hanenberg is head of product implementation, oral solid dose, Recipharm. His CPHI interview can be viewed in full here. Dr. Ali Rajabi-Siahboomi is vice president and chief innovation officer, ...
29, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announced that its plasma-protein based ...